News | Artificial Intelligence | April 02, 2019

Lunit Showcases AI Solution for Breast Cancer at SBI 2019

Lunit Insight for Mammography expected to get regulatory approvals beginning in July

Lunit Showcases AI Solution for Breast Cancer at SBI 2019

April 2, 2019 — Medical artificial intelligence (AI) startup Lunit announced its attendance at the Society of Breast Imaging (SBI) 2019 symposium, April 4-7 in Hollywood, Fla., where it will showcase its latest product for breast cancer detection, Lunit Insight for Mammography.

According to Lunit, the product is soon to be available for commercial sales, as the company is expecting to gain regulatory approvals in different regions. Lunit CEO Brandon Suh said Korea Ministry of Food and Drug Safety (MDFS) approval is expected as early as July 2019, followed by European CE approval by September 2019 and U.S. Food and Drug Administration (FDA) approval by early 2020.

Lunit Insight for Mammography was first revealed during the 2018 Radiological Society of North America annual meeting (RSNA 2018), presenting a 97 percent level of accuracy in the detection of breast cancer. Suh noted that false negative rates for mammography range from 10-30 percent, with false positive rates at around 95 percent. According to Suh, this costs more than $4 billion dollars for unnecessary recalls in the U.S. alone. He said that Lunit aims to reduce these costs by pulling more accurate information from accessible basic tests like mammography and use this clinically accurate information to increase efficiency in diagnostics.

Lunit is also developing what it calls a more sophisticated AI solution for digital breast tomosynthesis (DBT). DBT has been demonstrated by various large-scale studies to be superior to mammography in terms of breast cancer screening performance.

For more information: www.lunit.io

Related Content

Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography
News | Radiology Imaging | December 02, 2020
December 2, 2020 — Samsung Electronics Co., Ltd.
 Riverain Technologies will showcase its artificial intelligence solutions and enhancements at the now-virtual 2020 Radiological Society of North America Annual Meeting (RSNA).
News | Artificial Intelligence | December 02, 2020
December 2, 2020 — Riverain Technologies will showcase its...
Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius 3D Mammography exam
News | Breast Imaging | December 02, 2020
December 2, 2020 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s hea
Glassbeam Clinsights can help imaging departments capture service data to enhance operational efficiencies
News | Artificial Intelligence | December 02, 2020
December 2, 2020 — Hospitals and institutions face a significant challenge each year when it comes to the financial i
 Philips highlighted its expanding enterprise imaging informatics portfolio that is enabling healthcare providers to advance digital health transformation at RSNA 2020.
News | Enterprise Imaging | December 02, 2020
December 2, 2020 — Philips highlighted its expanding...
Lunit’s algorithm showed the best performance compared to other commercialized AI algorithms, ultimately reducing the workload of radiologists to classify mammography screenings
News | Artificial Intelligence | December 02, 2020
December 2, 2020 — Recent studies have shown that Lunit’s AI solution is as accurate as average radiologists when it
A cut-away view of the two cabins that compose the "CT-in-a-box" solution from GE to rapidly deploy CT scanners at hospitals amid a COVID surge. The CT room is completely separate from the control room to aid in sanitation and keeping technologists away from COVID patients.

A cut-away view of the two cabins that compose the "CT-in-a-box" solution from GE to rapidly deploy CT scanners at hospitals amid a COVID surge. The CT room is completely separate from the control room to aid in sanitation and keeping technologists away from COVID patients. Image by GE Healthcare.

Feature | Coronavirus (COVID-19) | December 01, 2020
December 1, 2020 — As hospitals see an influx of...
The GE Healthcare Allia IGS 71 angiography system. #RSNA #RSNA20 #RSNA2020

The GE Healthcare Allia IGS 71 angiography system.

News | Angiography | December 01, 2020
December 3, 2020 — GE Healthcare is introducing a new, smaller and lighter weight robotic driven ...
Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging. #RSNA20 #RSNA2020

Medical imaging artificial intelligence (AI) vendor Avicenna.AI announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging.
 

News | Stroke | December 01, 2020
December 1, 2020 – Medical imaging ...